Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future.
Katharina Kichko has written this book within her PhD program at the University of Greifswald.
Personalized Medicine Background.- The United States of America as Early Knower.- Germany as Follower.- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.